⌘K

Home/Filings/4/0001415889-23-014454

4//SEC Filing

Bashan Dror 4

Accession 0001415889-23-014454

CIK 0001006281other

View on SEC.gov Company Profile

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 6:50 AM ET

Size

6.2 KB

Accession

0001415889-23-014454

Insider Transaction Report

Form 4

Period: 2023-10-19

Protalix BioTherapeutics, Inc.PLX

DirectorPRESIDENT AND CEO

Transactions

Purchase
Common Stock
2023-10-19$1.40/sh+48,387$67,742→ 116,387 total
Purchase
Common Stock
2023-10-19$1.41/sh+16,129$22,742→ 132,516 total

Documents

1 file

4
form4-10202023_061001.xmlPrimary

Issuer

Protalix BioTherapeutics, Inc.

CIK 0001006281

Entity typeother

Related Parties

1

filerCIK 0001781450

Filing Metadata

Form type: 4
Filed: Oct 19, 8:00 PM ET
Accepted: Oct 20, 6:50 AM ET
Size: 6.2 KB

View on SEC.gov